Opioid plasma concentrations in methadone- and buprenorphine-maintained patients

Addiction Biology

Volumn 10, Issue 4, 2005, Pages 365-371

  Jagsch, Reinhold ^a   Gombas, Wolfgang ^b   Schindler, Shird Dieter ^b   Eder, Harald ^b   Moody, David E ^c   Fischer, Gabriele ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; METHADONE; OPIATE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; BUPRENORPHINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LONG-TERM CARE; MALE; METHADONE; MIDDLE AGED; OPIOID-RELATED DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT DROPOUTS; STATISTICS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 28744459340     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1080/13556210500358441     Document Type: Article

References (29)

1. Alburges ME, Huang W, Foltz RL, Moody DE (1996) Determination of methadone and its N-demethylation metabolites in biological specimens by GC-PICI-MS. J Anal Toxicol 20:362-368.
2. Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE (1988) A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. Clin Pharmacol Ther 43:72-78.
3. Bullingham RES, McQuay HJ, Porter EJB, Allen MC, Moore, RA (1982) Sublingual buprenorphine used postoperatively: ten hours plasma drug concentration analysis. Br J Clin Pharmacol 13:665-673.
4. Chiang CN, Hawks RL (2003) Pharmacokinetics of the combination tablet of buprenorphine and naloxone. Drug Alcohol Depend 70:39-47.
5. Chitasombat P, Willenbring ML, Maddux T, Severeide, N (1995) Reliability of methadone plasma levels in methadone maintenance. Am J Addict 4:351-355.
6. Dole VP, Nyswander M (1965) A medical treatment for diacetylmorphine (heroin) addiction. JAMA 193:80-84.
7. Emit (1983) Emit Assay Troubleshooting Guide. Palo Alto, CA: Syva Co.
8. Fischer G, Kasper S (eds) (1999) Therapiestandards der Opiatabhängigkeit. Wien: Universitätsklinik für Psychiatrie.
9. Fischer G, Gombas W, Eder H, Jagsch R, Peternell A, Stühlinger, Pezawas L, Aschauer HN, Kasper S (1999) Buprenorphine versus methadone maintenance for the treatment of opioid dependence. Addiction 94:1337-1347.
10. Gardner-Nix J (2002) Opioids causing peripheral edema. J Pain Symptom Manage 23:453-455.
11. Jasinski DR, Pevnick JS, Griffith JD (1978) Human pharmacology and abuse potential of the analgesic buprenorphine. Arch Gen Psychiatry 35:501-506.
12. Johnson RE, Jaffe JH, Fudala PJ (1992) A controlled trial of buprenorphine treatment for opioid dependence. JAMA 267:2750-2755.
13. Kouri EM, Lukas SE, Mendelson JH (1996) P300 assessment of opiate and cocaine users: Effects of detoxification and buprenorphine treatment. Biol Psychiatry 40:617-628.
14. Kreek MJ (1973) Medical safety and side effects of methadone in tolerant individuals. JAMA 223:665-668.
15. Langrod J, Lowinson J, Ruiz P (1981) Methadone treatment and physical complaints: a clinical analysis. Int J Addict 16:947-952.
16. Ling W, Charuvastra C, Collins JF, Batki S, Brown LS, Kintaudi P, Wesson, DR, McNicholas L, Tusel DJ, Malkerneker U, Renner JA, Santos E, Casadonte P, Fye C, Stine S, Wang RIH, Segal D (1998) Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial. Addiction 93:475-486.
17. Loimer N, Schmid R (1992) The use of plasma levels to optimize methadone maintenance treatment. Drug Alcohol Depend 30:241-246.
18. Moody DE, Laycock JD, Spanbauer AC, Crouch DJ, Foltz RL, Josephs JL, Amass L, Bickel WK (1997) Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry. J Anal Toxicol 21:406-414.
19. Moody DE, Slawson MH, Strain EC, Laycock JD, Spanbauer AC, Foltz RL (2002) A liquid chromatographic-electrospray ionisation-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies. Anal Biochem 306:31-39.
20. Nutt DJ (1997) Receptor pharmacology of buprenorphine. Res Clin Forums 19:9-15.
21. O'Conor LM, Woody G, Yeh H-S, Manny I, Dhopesh V (1991) Methadone and edema. J Subst Abuse Treat 8:153-155.
22. Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR (1997) Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry 54:713-720.
23. Seifert J, Metzner C, Paetzold W, Borsutzky M, Ohlmeier M, Passie T, Hauser U, Becker H, Wiese B, Emrich HM, Schneider U (2005) Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone. Addict Biol 10:157-164.
24. Strain EC, Stitzer ML, Liebson IA, Bigelow GE (1994) Comparison of buprenorphine and methadone in the treatment of opioid dependence. Am J Psychiatry 151:1025-1030.
25. Torrens M, Castillo C, San L, del Moral E, González ML, de la Torre R (1998) Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program. Drug Alcohol Depend 52:193-200.
26. Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE (1994) Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther 55:569-580.
27. Wang RIH, Wiesen RL, Lamid S, Roh BL (1974) Rating the presence and severity of opiate dependence. Clin Pharmacol Ther 7:653-658.
28. Wolff K, Hay A, Raistrick D, Calvert R, Feely M (1991b) Measuring compliance in methadone maintenance patients: use of a pharmacological indicator to 'estimate' methadone plasma levels. Clin Pharmacol Ther 50:199-207.
29. Wolff K, Sanderson M, Hay AW, Raistrick D (1991a) Methadone concentrations in plasma and their relationship to drug dosage. Clin Chem 37:205-209.